NEW ORLEANS--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to creating novel solutions that treat urothelial and specialty cancers, today highlights new data on real-world experience utilizing the antegrade approach via nephrostomy tube for administration of JELMYTO (mitomycin) for pyelocalyceal solution. This data adds to a growing body of evidence on the safety and efficacy profile of the antegrade method of administration for JELMYTO. These data were presented during a podium presentation at the 2022 American Urological Association (AUA) annual meeting in New Orleans, Louisiana.
JELMYTO is efficacious as a chemoablative agent in adult patients with low grade upper tract urothelial cancer, and while its FDA approved for both antegrade and retrograde administration, prior reports are limited to the retrograde experience, said Kyle Rose, MD, Urologic Oncology Fellow at Moffitt Cancer Center in Tampa, Fla., and study investigator. These data provide additional evidence that instillation via a nephrostomy tube is an effective instillation method with a safety profile that offers an encouraging option to appropriate patients.
Dr. Rose presented the abstract Antegrade Administration of Reverse Thermal Mytomycin Gel for Primary Chemoablation of Upper Tract Carcinoma via Percutaneous Nephrostomy Tube: A Multi-Institutional Real-World Experience (Abstract PD58-06) during a podium presentation at the AUA annual meeting on Monday, May 16.
All 71 patients in the Phase 3 OLYMPUS trial utilized the retrograde approach to administer JELMYTO, therefore we are pleased to see real-world evidence that supports the utilization of the antegrade approach giving physicians and patients more options to administer JELMYTO based on their preference and experience, said Mark Schoenberg, MD, Chief Medical Officer, UroGen.
About This Study
The real-world data from this retrospective analysis was pooled from Moffitt Cancer Center, Tampa, FL; University of Missouri School of Medicine, Columbia, MO; The University of Texas MD Anderson Cancer Center, Houston, TX; and Mayo Clinic, Rochester, MN.
Twenty-six patients received nephrostomy tube administration of JELMYTO, six patients (23%) had solitary kidneys. Nine patients (35%) went on to receive at least one dose of maintenance therapy. Ureteral stenosis occurred in four patients (15%). Other adverse events included fatigue (27%), flank pain (19%), urinary tract infection (12%), sepsis (8%) and hematuria (8%). No patients had impaired renal function during follow-up and no deaths occurred.
Thirteen patients (50%) exhibited a complete response at post-induction ureteroscopy while 12 patients (46%) had a partial response. One patient experienced progression to invasive disease and required a nephroureterectomy. At a median follow-up of seven months (IQR 3-9) post-induction, no patients who experienced a complete response recurred.
The limitations of this study include the retrospective nature, small sample size, and pooled reporting of results. There is a need for larger studies with longer follow-up to study more conclusively any potential advantages of antegrade JELMYTO administration when compared to retrograde instillation.
About the Pivotal OLYMPUS Study
OLYMPUS (Optimized DeLiverY of Mitomycin for Primary UTUC Study) was an open-label, single-arm Phase 3 clinical study of UGN-101 JELMYTO (mitomycin) for pyelocalyceal solution, to evaluate the safety, tolerability and tumor ablative effect of JELMYTO in patients with low-grade Upper Tract Urothelial Cancer UTUC (LG UTUC). Seventy-one patients were treated at clinical sites across the United States and Israel. Study participants were treated with six weekly instillations of JELMYTO administered via a standard catheter. Four to six weeks following the last instillation, patients underwent a Primary Disease Evaluation (PDE) to determine Complete Response (CR), the primary endpoint of the study. PDE involved a ureteroscopy and wash cytology, a standard microscopic test of cells obtained from the urine to detect cancer and for cause biopsy. Patients who achieved a CR at the PDE timepoint were eligible for the maintenance phase of the trial, during which they could receive monthly maintenance instillations for up to 12 months and were assessed to determine the durability of response with JELMYTO.
In the OLYMPUS study, data was generated for the retrograde administration of JELMYTO. In that study population ureteric obstruction was reported in 58% (n=41) of patients receiving JELMYTO, including 17% (n=12) of patients who experienced Grade 3 obstruction.
About LG UTUC
LG UTUC is a rare disease managed by endoscopic methods and radical nephroureterectomy. Endoscopic resection and laser ablation attempt to preserve the kidney, though there is a high risk of recurrence that may eventually necessitate removal of the kidney. Although kidney removal is the gold standard for treatment of high-grade UTUC, it may be over-treatment in LG UTUC, as kidney removal offers similar five-year survival as kidney-sparing procedures but is associated with significant morbidity. JELMYTO is efficacious as a primary chemoablative therapy in patients with LG UTUC.
About JELMYTO
JELMYTO (mitomycin) for pyelocalyceal solution is a mitomycin-containing reverse thermal gel containing 4 mg mitomycin per mL gel indicated for primary chemoablative treatment of LG UTUC in adults. It is recommended for primary treatment of biopsy-proven LG UTUC in patients deemed appropriate candidates for renal-sparing therapy. JELMYTO is a viscous liquid when cooled and becomes a semi-solid gel at body temperature. The drug slowly dissolves over four to six hours after instillation and is removed from the urinary tract by normal urine flow and voiding. It is approved for administration in a retrograde manner via ureteral catheter or antegrade through nephrostomy tube. The delivery system allows the initial liquid to coat and conform to the upper urinary tract anatomy. The eventual semisolid gel allows for chemoablative therapy to remain in the collecting system for four to six hours without immediately being diluted or washed away by urine flow.
APPROVED USE FOR JELMYTO
JELMYTO is a prescription medicine used to treat adults with a type of cancer of the lining of the upper urinary tract including the kidney called low-grade Upper Tract Urothelial Cancer (LG-UTUC).
IMPORTANT SAFETY INFORMATION
You should not receive JELMYTO if you have a hole or tear (perforation) of your bladder or upper urinary tract.
Before receiving JELMYTO, tell your healthcare provider about all your medical conditions, including if you:
Females who are able to become pregnant: You should use effective birth control (contraception) during treatment with JELMYTO and for 6 months after the last dose.
Males being treated with JELMYTO: If you have a female partner who is able to become pregnant, you should use effective birth control (contraception) during treatment with JELMYTO and for 3 months after the last dose.
How will I receive JELMYTO?
After receiving JELMYTO:
JELMYTO may cause serious side effects, including:
The most common side effects of JELMYTO include: urinary tract infection, blood in your urine, side pain, nausea, trouble with urination, kidney problems, vomiting, tiredness, stomach (abdomen) pain.
You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration. Visit http://www.fda.gov/medwatch or call 1800FDA1088. You may also report side effects to UroGen Pharma at 1-855-987-6436.
Please see JELMYTO Full Prescribing Information, including the Patient Information, for additional information
About UroGen Pharma Ltd.
UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options.
UroGen has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGens sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGens first commercial product Jelmyto (mitomycin) for pyelocalyceal solution, and investigational treatment UGN-102 (mitomycin) for intravesical solution for patients with low-grade non-muscle invasive bladder cancer, are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit http://www.urogen.com to learn more or follow us on Twitter, @UroGenPharma.
Forward-Looking Statements
This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding whether future studies could demonstrate any potential advantages of antegrade administration of JELMYTO as compared to retrograde instillation; optimism regarding the effectiveness of the antegrade approach; RTGels potential to improve the therapeutic profiles of existing drugs; and UroGens sustained release technology making local delivery potentially more effective as compared to other treatment options. These statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to: results from initial reports of the antegrade administration of JELMYTO may not be indicative of results that may be observed in the future; potential safety and other complications from the antegrade administration of JELMYTO; the timing and success of clinical trials and potential safety and other complications thereof; the ability to obtain and maintain regulatory approval; the labelling for any approved product; the scope, progress and expansion of developing and commercializing UroGens product candidates; the size and growth of the market(s) therefor and the rate and degree of market acceptance thereof vis--vis alternative therapies. In light of these risks and uncertainties, and other risks and uncertainties that are described in the Risk Factors section of UroGens Form 10-Q filed with the SEC on May 10, 2022 and other filings that UroGen makes with the SEC from time to time (which are available at http://www.sec.gov), the events and circumstances discussed in such forward-looking statements may not occur, and UroGens actual results could differ materially and adversely from those anticipated or implied thereby. Any forward-looking statements speak only as of the date of this press release and are based on information available to UroGen as of the date of this release.
Link:
- Center for Alternative Medicine Ohio [Last Updated On: June 13th, 2016] [Originally Added On: June 13th, 2016]
- Natural Alternative Medicine [Last Updated On: June 13th, 2016] [Originally Added On: June 13th, 2016]
- Alternative Medicine, Holistic Doctors,Naturopathic ... [Last Updated On: June 17th, 2016] [Originally Added On: June 17th, 2016]
- Complementary and Alternative Medicine Guide | University ... [Last Updated On: June 19th, 2016] [Originally Added On: June 19th, 2016]
- Complementary and Alternative Medicine Guide | University ... [Last Updated On: June 19th, 2016] [Originally Added On: June 19th, 2016]
- Alternative medicine - Wikipedia, the free encyclopedia [Last Updated On: July 9th, 2016] [Originally Added On: July 9th, 2016]
- Complementary and Alternative Medicine (CAM): Health and ... [Last Updated On: July 10th, 2016] [Originally Added On: July 10th, 2016]
- Complementary and alternative medicine - Mayo Clinic [Last Updated On: July 12th, 2016] [Originally Added On: July 12th, 2016]
- Herbalism - Wikipedia, the free encyclopedia [Last Updated On: July 14th, 2016] [Originally Added On: July 14th, 2016]
- Home, Alternative Medicine, Complementary Medicine ... [Last Updated On: July 25th, 2016] [Originally Added On: July 25th, 2016]
- Alternative Medicine | HowStuffWorks [Last Updated On: July 29th, 2016] [Originally Added On: July 29th, 2016]
- Complementary and Alternative Medicine - KidsHealth [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Complementary and Alternative Medicine [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Alternative Medicine Degree - Online Schools & Accredited ... [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Complementary and alternative medicine | womenshealth.gov [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Alternative Medicine - CHLI [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Topical Index - Alternatives to Medicine - The Skeptic's ... [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Alternative Medicine Salary | How Much Can an Alternative ... [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Alternative Medicine Degrees, Online Alternative Medicine ... [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- American Institute of Alternative Medicine [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Alternative Medicine in Utah [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Open International University for Alternative Medicines [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Alternative Medicine, Home Remedy and Natural Cures [Last Updated On: July 31st, 2016] [Originally Added On: July 31st, 2016]
- Complementary, Alternative, or Integrative Health: Whats ... [Last Updated On: August 10th, 2016] [Originally Added On: August 10th, 2016]
- About complementary medicines - Live Well - NHS Choices [Last Updated On: August 21st, 2016] [Originally Added On: August 21st, 2016]
- 5 Types of Complementary and Alternative Medicine (CAM) [Last Updated On: August 21st, 2016] [Originally Added On: August 21st, 2016]
- Alternative Medicine Solution [Last Updated On: August 21st, 2016] [Originally Added On: August 21st, 2016]
- Depression (major depression) Alternative medicine - Mayo Clinic [Last Updated On: August 21st, 2016] [Originally Added On: August 21st, 2016]
- Alternative Medicine | Glaucoma Research Foundation [Last Updated On: August 21st, 2016] [Originally Added On: August 21st, 2016]
- Alternative Medicine - Christian Research Institute [Last Updated On: August 21st, 2016] [Originally Added On: August 21st, 2016]
- Natural Alternative Medicine, Herbal Remedies & Holistic ... [Last Updated On: August 30th, 2016] [Originally Added On: August 30th, 2016]
- Alternative Treatments for High Blood Pressure - WebMD [Last Updated On: September 11th, 2016] [Originally Added On: September 11th, 2016]
- Alternative Medicine, Complementary Medicine, definitions of ... [Last Updated On: September 11th, 2016] [Originally Added On: September 11th, 2016]
- Alternative Medicine - healthworldnet.com [Last Updated On: September 11th, 2016] [Originally Added On: September 11th, 2016]
- Alternative Medicine | What Is Alternative Medicine? [Last Updated On: September 11th, 2016] [Originally Added On: September 11th, 2016]
- Alternative medicine - Psychology Wiki - Wikia [Last Updated On: September 11th, 2016] [Originally Added On: September 11th, 2016]
- Alternative medicine - RationalWiki [Last Updated On: September 11th, 2016] [Originally Added On: September 11th, 2016]
- New Jersey Alternative Medicine | NJ Medical Marijuana Doctor [Last Updated On: September 16th, 2016] [Originally Added On: September 16th, 2016]
- Complementary and Alternative Medicine (CAM) - National ... [Last Updated On: September 22nd, 2016] [Originally Added On: September 22nd, 2016]
- Complementary and Alternative Medicine (CAM) [Last Updated On: September 22nd, 2016] [Originally Added On: September 22nd, 2016]
- Medicine - Wikipedia, the free encyclopedia [Last Updated On: October 1st, 2016] [Originally Added On: October 1st, 2016]
- Alternative medicine - Wikipedia [Last Updated On: November 29th, 2016] [Originally Added On: November 29th, 2016]
- Alternative Medicine: Types, Uses & Information - Disabled ... [Last Updated On: November 30th, 2016] [Originally Added On: November 30th, 2016]
- Alternative Medicine Journals - Open Access Journals [Last Updated On: November 30th, 2016] [Originally Added On: November 30th, 2016]
- Ed's Guide to Alternative Therapies - pathguy.com [Last Updated On: December 8th, 2016] [Originally Added On: December 8th, 2016]
- Complementary and Alternative Medicine (CAM) Overview [Last Updated On: December 25th, 2016] [Originally Added On: December 25th, 2016]
- Grad Schools Alternative Medicine Graduate Programs [Last Updated On: January 11th, 2017] [Originally Added On: January 11th, 2017]
- Alternative Medicine Career Information and Education ... [Last Updated On: January 11th, 2017] [Originally Added On: January 11th, 2017]
- Alternative Medicine | Category | Fox News [Last Updated On: January 11th, 2017] [Originally Added On: January 11th, 2017]
- Alternative Medicine Degree, BS - Everglades University [Last Updated On: January 11th, 2017] [Originally Added On: January 11th, 2017]
- Types of Complementary and Alternative Medicine | Johns ... [Last Updated On: January 14th, 2017] [Originally Added On: January 14th, 2017]
- Alternative Medicine | Duke University Press [Last Updated On: January 23rd, 2017] [Originally Added On: January 23rd, 2017]
- Alternative medicine becoming more popular - WSIL TV [Last Updated On: February 6th, 2017] [Originally Added On: February 6th, 2017]
- Peroxide ingestion, promoted by alternative medicine, can be ... - Science Daily [Last Updated On: February 6th, 2017] [Originally Added On: February 6th, 2017]
- Marijuana tension between clinical, alternative medicine ... - Washington Times [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Bill to rein in alternative medicine practitioners - Bangalore Mirror [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Cannabis providers feel tension between clinical and alternative medicine - The Cannabist [Last Updated On: February 10th, 2017] [Originally Added On: February 10th, 2017]
- Happy Healthy YOU - Tillsonburg News [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- History of alternative medicine - Wikipedia [Last Updated On: February 22nd, 2017] [Originally Added On: February 22nd, 2017]
- Alternative Medicine Conferences | Traditional Medicine ... [Last Updated On: February 24th, 2017] [Originally Added On: February 24th, 2017]
- Alternative medicine to treat pain and other ailments on the rise locally - Rockford Register Star [Last Updated On: February 25th, 2017] [Originally Added On: February 25th, 2017]
- Holistic medicine, what you need to know - Arizona Sonoro News [Last Updated On: February 26th, 2017] [Originally Added On: February 26th, 2017]
- Why is alternative medicine so popular? - Alternative ... [Last Updated On: February 26th, 2017] [Originally Added On: February 26th, 2017]
- Potential dangers and dubious history of alternative medicine are often unknown to its consumers - MinnPost [Last Updated On: February 28th, 2017] [Originally Added On: February 28th, 2017]
- There Is No Such Thing as Alternative Medicine - Big Think [Last Updated On: February 28th, 2017] [Originally Added On: February 28th, 2017]
- OPENING THE PLAYBOOK ON ALTERNATIVE MEDICINE - Dope Magazine [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- New form of alternative medicine comes to OU - Oaklandpostonline [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- Evangelical Alternative Medicine - First Things (blog) [Last Updated On: March 4th, 2017] [Originally Added On: March 4th, 2017]
- Alternative medicine grows in Sugar Land, Missouri City - Community Impact Newspaper [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Ask a Doctor: Is there an alternative medicine treatment for constant pain? - Chattanooga Times Free Press [Last Updated On: March 7th, 2017] [Originally Added On: March 7th, 2017]
- Abstracts: Obamacare Replacement, Alternative Medicine, and More - Undark Magazine [Last Updated On: March 7th, 2017] [Originally Added On: March 7th, 2017]
- For Prairie Village practitioner, personal experience led to interest in alternative medicine techniques - Shawnee Mission Post [Last Updated On: March 7th, 2017] [Originally Added On: March 7th, 2017]
- Medicine with a side of mysticism: Top hospitals promote unproven therapies - STAT [Last Updated On: March 7th, 2017] [Originally Added On: March 7th, 2017]
- Major Hospitals are Offering Alternative Therapies. Is This Medicine ... - Big Think [Last Updated On: March 10th, 2017] [Originally Added On: March 10th, 2017]
- Financial Planning + Alternative Medicine - March 8, 2017 ... - KHTS Radio [Last Updated On: March 10th, 2017] [Originally Added On: March 10th, 2017]
- Alternative medicine becomes a lucrative business for U.S. top ... - FierceHealthcare [Last Updated On: March 10th, 2017] [Originally Added On: March 10th, 2017]
- Premier U.S. Hospitals Are Selling Unproven Alternative Therapies ... - KQED [Last Updated On: March 11th, 2017] [Originally Added On: March 11th, 2017]
- Speakers lay stress on use of alternative medicine - The Nation [Last Updated On: March 11th, 2017] [Originally Added On: March 11th, 2017]
- Top U.S. hospitals promote unproven medicine with a side of ... - PBS - PBS NewsHour [Last Updated On: March 12th, 2017] [Originally Added On: March 12th, 2017]
- Charity Commission consults on future of alternative medicine ... - Civil Society Media [Last Updated On: March 19th, 2017] [Originally Added On: March 19th, 2017]